Opening Asia for Russia

Egypt to launch production of Sputnik V

12.02.2022 116 просмотров

Technologies are transferred to Cairo to meet domestic needs, as well as export the drug to other countries in the Middle East and Africa.


The launch of production in Egypt of the Sputnik V vaccine against the new coronavirus is expected within six months. This was reported to TASS on Thursday in the office of the chairman of the board of directors of Minafarm, which signed an agreement with the Russian Direct Investment Fund (RDIF) about a year ago on the localization of production.

Russia for examination, the final stage of launching production is approaching after the final approval of the drug by the Egyptian pharmaceutical regulator - the Office of Medicines, the company said. “All this takes six months.” At the same time, Minafarm admitted that there are certain difficulties with the availability of materials and equipment for the production of vaccines.

Negotiations between RDIF and the Egyptian Minafarm ended in April 2021 with the signing of an agreement on the annual production of over 40 million doses of vaccine . Technologies are being transferred to Cairo to meet domestic needs, as well as export the drug to other countries in the Middle East and Africa.

In Egypt, almost all WHO-approved coronavirus vaccines are currently allowed for use, including its own analogue of Sinovac-Vaxera, produced by with Chinese technology. However, Sputnik V, Pfizer and Johnson & Johnson.

Новости партнёров